Recruiting

Automated insulin pumps during labor for pregnant people with type 1 diabetes

Plain-English translation of NCT06883344 on ClinicalTrials.gov ↗ · Source last updated July 2026 · Translation generated July 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This trial is testing whether automated insulin delivery (AID) systems—smart pumps that automatically adjust insulin doses—can safely manage blood sugar during labor and delivery for people with type 1 diabetes. Right now, hospitals use intravenous insulin (IV insulin given through a needle in your vein) during labor. This study wants to see if the AID system you may already be using can work just as well or better during this critical time.

Managing blood sugar during labor is challenging and important for both you and your baby. The current standard care works, but it requires an IV and close monitoring. This trial exists to see if this treatment could offer a safer, less invasive option that lets you stay more in control during one of the most important moments of your life.

Do you qualify?

You likely qualify if…

you are currently pregnant and at least 34 weeks along
you have been diagnosed with type 1 diabetes for at least 1 year
you have been using a commercially available automated insulin delivery system since at least 28 weeks of pregnancy
you are carrying one baby (not twins or multiples)
you speak English or Spanish

You likely don't qualify if…

you are expecting twins or multiples
you are planning to have a planned cesarean section
you are taking medications that significantly affect how your body handles blood sugar
there has been a loss of fetal heart activity
you have a physical or mental health condition that would make it hard to participate safely

What participation looks like

If you join this trial, you'll be randomly assigned to either use your automated insulin delivery system during labor or receive the standard intravenous insulin. The trial team will monitor your blood sugar and your baby's health closely throughout labor and delivery, just as they normally would. After delivery, they'll check on how well blood sugar was controlled for both you and your newborn, and they'll ask you about your birth experience.

AI-generated summary from trial data · Jul 15, 2026 · Not medical advice

Trial locations(3 sites)

United States

University of California, Los Angeles, Los Angeles, California

University of California, San Diego, San Diego, California

University of California, San Francisco, San Francisco, California